Fcf Advisors LLC Bristol Myers Squibb CO Transaction History

Fcf Advisors LLC

$422 Million
Q3 2024

A detailed history of Fcf Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Fcf Advisors LLC holds 122,341 shares of BMY stock, worth $6.51 Million. This represents 1.5% of its overall portfolio holdings.

Number of Shares

122,341

Previous 112,845 8.42%

Holding current value

$6.51 Million

Previous $4.69 Million 35.1%

% of portfolio

1.5%

Previous 1.17%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$39.66 - $51.75 $376,611 - $491,418	9,496 Added 8.42%	122,341 $6.33 Million
Q2 2024 Jul 18, 2024	BUY	$40.25 - $52.99 $98,210 - $129,295	2,440 Added 2.21%	112,845 $4.69 Million
Q1 2024 Apr 12, 2024	BUY	$47.98 - $54.4 $388,398 - $440,368	8,095 Added 7.91%	110,405 $5.99 Million
Q4 2023 Jan 04, 2024	BUY	$48.48 - $57.85 $3.29 Million - $3.93 Million	67,856 Added 196.95%	102,310 $5.25 Million
Q3 2023 Oct 10, 2023	SELL	$57.89 - $64.73 $31,029 - $34,695	-536 Reduced 1.53%	34,454 $2 Million
Q2 2023 Jul 19, 2023	BUY	$63.71 - $70.74 $323,391 - $359,076	5,076 Added 16.97%	34,990 $2.24 Million
Q1 2023 Apr 19, 2023	BUY	$65.71 - $74.53 $524,760 - $595,196	7,986 Added 36.42%	29,914 $2.07 Million
Q4 2022 Feb 03, 2023	SELL	$68.48 - $81.09 $33,692 - $39,896	-492 Reduced 2.19%	21,928 $1.58 Million
Q3 2022 Oct 12, 2022	SELL	$0.13 - $76.84 $529 - $313,123	-4,075 Reduced 15.38%	22,420 $1.59 Million
Q2 2022 Jul 20, 2022	SELL	$72.62 - $79.98 $2.22 Million - $2.44 Million	-30,564 Reduced 53.57%	26,495 $2.04 Million
Q1 2022 Apr 28, 2022	BUY	$61.48 - $73.72 $2.02 Million - $2.42 Million	32,786 Added 135.07%	57,059 $4.17 Million
Q2 2021 Jul 30, 2021	BUY	$61.91 - $67.42 $1.5 Million - $1.64 Million	24,273 New	24,273 $1.62 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fcf Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fcf Advisors LLC with notifications on news.

Account